相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Acute and Long-Term Salt Depletion and β-blockade: Plasma Renin Activity Response and its Relation to Blood Pressure Reduction in Long-Term Treatment
Ingolf Nielsen et al.
ACTA MEDICA SCANDINAVICA (2010)
Atenolol Administered once Daily in Primary Hypertension
Ove R. Nilsson et al.
ACTA MEDICA SCANDINAVICA (2010)
Aliskiren-binding increases the half life of renin and prorenin in rat aortic vascular smooth muscle cells
Wendy W. Batenburg et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Newly developed renin and prorenin assays and the clinical evaluation of renin inhibitors
Maarten A. D. H. Schalekamp et al.
JOURNAL OF HYPERTENSION (2008)
Efficacy and safety of the direct renin inhibitor aliskiren and ramipril alone or in combination in patients with diabetes and hypertension
Yagiz Uresin et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2007)
2007 guidelines for the management of arterial hypertension
Giuseppe Mancia et al.
JOURNAL OF HYPERTENSION (2007)
Aliskiren, an oral renin inhibitor, provides dose-dependent efficacy and sustained 24-hour blood pressure control in patients with hypertension
Byung-Hee Oh et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Beta-blockers for hypertension
C. S. Wiysonge et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2007)
Renin inhibition with aliskiren provides additive anti hypertensive efficacy when used in combination with hydrochlorothiazide
Alberto Villamil et al.
JOURNAL OF HYPERTENSION (2007)
Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan
James L. Pool et al.
AMERICAN JOURNAL OF HYPERTENSION (2007)
Re-examining the efficacy of β-blockers for the treatment of hypertension:: a meta-analysis
N Khan et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2006)
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes - Principal results of the Conduit Artery Function Evaluation (CAFE) study
B Williams et al.
CIRCULATION (2006)
Conformational changes in prorenin during renin inhibition in vitro and in vivo
J Ménard et al.
JOURNAL OF HYPERTENSION (2006)
Is the level of evidence for the use of beta-blockers in acute myocardial infarction satisfactory enough?
IB Mrdovic
EUROPEAN HEART JOURNAL (2006)
The diabetogenic potential of thiazide-type diuretic and beta-blocker combinations in patients with hypertension
JM Mason et al.
JOURNAL OF HYPERTENSION (2005)
Should β blockers remain first choice in the treatment of primary hypertension?: A meta-analysis
LH Lindholm et al.
LANCET (2005)
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA):: a multicentre randomised controlled trial
B Dahlöf et al.
LANCET (2005)
The impart of ACE inhibitors or angiotensin II type 1 receptor blockers on the development of new-onset type 2 diabetes
EL Gillespie et al.
DIABETES CARE (2005)
The cardiovascular continuum and renin-angiotensin-aldosterone system blockade
V Dzau
JOURNAL OF HYPERTENSION (2005)
Benefits from angiotensin-converting enzyme inhibitor 'beyond blood pressure lowering': beyond blood pressure or beyond the brachial artery?
K Hirata et al.
JOURNAL OF HYPERTENSION (2005)
Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients
AH Gradman et al.
CIRCULATION (2005)
Guidelines for management of hypertension: Report of the fourth working party of the British Hypertension Society, 2004 - BHSIV
B Williams et al.
JOURNAL OF HUMAN HYPERTENSION (2004)
Plasma renin activity levels in hypertensive persons: Their wide range and lack of suppression in diabetic and in most elderly patients
MH Alderman et al.
AMERICAN JOURNAL OF HYPERTENSION (2004)
Structure-based design of aliskiren, a novel orally effective renin inhibitor
JM Wood et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials
MR Law et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100) - Comparison with enalapril
J Nussberger et al.
HYPERTENSION (2002)
Association between blood pressure level and the risk of myocardial infarction, stroke, and total mortality -: The cardiovascular health study
BM Psaty et al.
ARCHIVES OF INTERNAL MEDICINE (2001)
Pulse pressure and risk for myocardial infarction and heart failure in the elderly
V Vaccarino et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)
Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients
J Blacher et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
分享论文
